About Verra Therapeutics
Verra Therapeutics is a private company based in Lansing, New York, incorporated in 2024 in Delaware. It has reported $205,000 raised in one offering on Form D since February 2026. Its chief executive is Christopher Prince.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | Feb 18, 2026 | $205,000of $450K target | 6 | $34,167 | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Verra Therapeutics's Form D filed Feb 18, 2026.
JC
Jeffrey Calkins
Treasurer and director
CP
Christopher Prince
Chief Executive Officer
CP
Christopher Prince
President and director
CP
Christopher Prince
Secretary and director